Which returned more over the last year, IBB or USHY?

In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and USHY returned +3.3%, so IBB returned more. One year is one year; the longer windows are in the table.

Which is cheaper, IBB or USHY?

IBB charges 0.44% a year and USHY charges 0.08%, so USHY is cheaper. Fees come from each fund's prospectus.

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

IBB vs USHY: how they differ

IBB and USHY hold 0% of their weight in the same names, and IBB returned more over the year.

iShares Biotechnology ETF and iShares Broad USD High Yield Corporate Bond ETF.

What they hold in common

By the books each fund has filed, IBB and USHY hold 0% of their money in the same securities at the same weight.

Largest positions each one holds and the other does not
Only in IBB	Only in USHY
Vertex Pharmaceuticals, Inc. 8.09%	1261229 BC LTD 0.48%
Amgen, Inc. 7.84%	ECHOSTAR CORP 0.42%
Gilead Sciences, Inc. 6.85%	QUIKRETE HOLDINGS INC 0.29%
Regeneron Pharmaceuticals, Inc. 4.91%	SV RNO PROPERTY OWNER 1 0.28%
Argenx SE 3.76%	CLOUD SOFTWARE GRP INC 0.27%
Alnylam Pharmaceuticals, Inc. 3.12%	WULF COMPUTE LLC 0.26%
Natera, Inc. 2.89%	ASURION LLC/ASURION CO 0.26%
Revolution Medicines, Inc. 2.78%	HUB INTERNATIONAL LTD 0.26%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.

IBB and USHY on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
	IBB iShares Biotechnology ETF	USHY iShares Broad USD High Yield Corporate Bond ETF
Where it sits	Core index fund	Core index fund
Issuer	iShares	iShares
What it is	Biotechnology	Broad USD High Yield Corporate Bond
Total return, 1 year	+41.5%	+3.3%
S&P 500 over the same days	+17.5%	+17.5%
Gap to the S&P 500	+24.0 pts	−14.2 pts
Expense ratio	0.44%	0.08%
Holdings	248	1894

IBB in plain words

IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 248 positions, with the top ten at 44.8%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.

USHY in plain words

USHY is a bond fund tracking the Broad USD High Yield Corporate Bond. Over the year to Sep 11, 2026 it returned +3.3% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year.

Questions people ask

Which returned more over the last year, IBB or USHY?: In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and USHY returned +3.3%, so IBB returned more. One year is one year; the longer windows are in the table.
Which is cheaper, IBB or USHY?: IBB charges 0.44% a year and USHY charges 0.08%, so USHY is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

IBB against USHY, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, IBB against USHY, data as of Sep 12, 2026. https://etfiq.com/compare/any/IBB-USHY Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources